Andere talen OssDsign AB

Aandelen

OSSD

SE0012570448

Beurs gesloten - Nasdaq Stockholm Andere beurzen 17:24:11 07-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
10,34 ^SEK	+0,39%		+6,16%	+29,25%

29/04	OssDsign AB (publ) breidt militaire toegang uit met nieuw contract voor 100 extra VA orthopedische ziekenhuizen	CI
02/04	OssDsign tekent driejarig leveringscontract met Premier voor bot- en botsubstituutproducten	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

OssDsign expands military access with new contract covering 100 additional VA orthopedic hospitals	29/04
OssDsign AB Expands Military Access with New Contract Covering 100 Additional VA Orthopedic Hospitals	29/04
Certain Shares of OssDsign AB are subject to a Lock-Up Agreement Ending on 15-APR-2024.	15/04
OssDsign: Another quarter of triple-digit Catalyst growth expected	11/04
OssDsign Signs Three-year Supply Contract with Premier for Bone, Bone Substitute Products	02/04
OssDsign awarded long-term agreement with Premier, Inc.	02/04
OssDsign AB Wins Long-Term Agreement with Premier, Inc	02/04
OssDsign: Update after HC seminar and news in the spinal fusion market	07/03
Sweden's OssDsign Names Chief Technical Officer	29/02
OssDsign appoints Tom Buckland as Chief Technical Officer	29/02
OssDsign AB (publ.) Appoints Tom Buckland as Chief Technical Officer	29/02
OssDsign: Restructuring completed, focus on 2024	07/02
OssDsign AB (publ) publishes year-end report 2023	06/02
OssDsign AB Reports Earnings Results for the Full Year Ended December 31, 2023	06/02
OssDsign AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	06/02
OssDsign: Right time to fuse the spine	29/01
12-month data from the clinical study of OssDsign Catalyst™ published in Biomedical Journal of Scientific & Technical Research	24/01
OssDsign AB (publ.) Announces 12-Month Data from the Clinical Study Top Fusion	24/01
OssDsign reports exceptional data from the clinical study TOP FUSION	09/01
OssDsign AB Reports Exceptional Data from the Clinical Study TOP FUSION	09/01

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen OssDsign AB

Aandelen

OSSD

SE0012570448

Andere talen

Filters